BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 9865388)

  • 1. Synthesis and anti-human immunodeficiency virus type 1 integrase activity of hydroxybenzoic and hydroxycinnamic acid flavon-3-yl esters.
    Desideri N; Sestili I; Stein ML; Tramontano E; Corrias S; La Colla P
    Antivir Chem Chemother; 1998 Nov; 9(6):497-509. PubMed ID: 9865388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
    Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
    Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationally designed dual inhibitors of HIV reverse transcriptase and integrase.
    Wang Z; Bennett EM; Wilson DJ; Salomon C; Vince R
    J Med Chem; 2007 Jul; 50(15):3416-9. PubMed ID: 17608468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anti-HIV activity of some [Nucleoside Reverse Transcriptase Inhibitor]-C5'-linker-[Integrase Inhibitor] heterodimers as inhibitors of HIV replication.
    Sugeac E; Fossey C; Ladurée D; Schmidt S; Laumond G; Aubertin AM
    J Enzyme Inhib Med Chem; 2004 Dec; 19(6):497-509. PubMed ID: 15662954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of 3-hydroxy-3-phenylpropanoate ester–AZT conjugates as potential dual-action HIV-1 Integrase and Reverse Transcriptase inhibitors.
    Manyeruke MH; Olomola TO; Majumder S; Abrahams S; Isaacs M; Mautsa N; Mosebi S; Mnkandhla D; Hewer R; Hoppe HC; Klein R; Kaye PT
    Bioorg Med Chem; 2015 Dec; 23(24):7521-8. PubMed ID: 26775541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-picornavirus activity of synthetic flavon-3-yl esters.
    Conti C; Mastromarino P; Sgro R; Desideri N
    Antivir Chem Chemother; 1998 Nov; 9(6):511-5. PubMed ID: 9865389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.
    Xue P; Lu HH; Zhu YY; Ju XL; Pannecouque C; Zheng XJ; Liu GY; Zhang XL; Gu SX
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1640-1643. PubMed ID: 28314598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.
    Artico M; Di Santo R; Costi R; Novellino E; Greco G; Massa S; Tramontano E; Marongiu ME; De Montis A; La Colla P
    J Med Chem; 1998 Oct; 41(21):3948-60. PubMed ID: 9767632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of pyrimidine and quinolone conjugates as a scaffold for dual inhibitors of HIV reverse transcriptase and integrase.
    Wang Z; Vince R
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1293-6. PubMed ID: 18226894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
    Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
    Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of novel lipid-functionalized PNA monomers as potential HIV-1 non-nucleoside reverse transcriptase and/or integrase inhibitors.
    Thomas MG; Maga G; Mouscadet JF; Howarth NM
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1063-6. PubMed ID: 18058537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase.
    Melamed JY; Egbertson MS; Varga S; Vacca JP; Moyer G; Gabryelski L; Felock PJ; Stillmock KA; Witmer MV; Schleif W; Hazuda DJ; Leonard Y; Jin L; Ellis JD; Young SD
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5307-10. PubMed ID: 18774711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines.
    Brzozowski Z; Saczewski F; Sanchez T; Kuo CL; Gdaniec M; Neamati N
    Bioorg Med Chem; 2004 Jul; 12(13):3663-72. PubMed ID: 15186851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
    King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
    J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chicoric acid analogues as HIV-1 integrase inhibitors.
    Lin Z; Neamati N; Zhao H; Kiryu Y; Turpin JA; Aberham C; Strebel K; Kohn K; Witvrouw M; Pannecouque C; Debyser Z; De Clercq E; Rice WG; Pommier Y; Burke TR
    J Med Chem; 1999 Apr; 42(8):1401-14. PubMed ID: 10212126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity.
    Esposito F; Ambrosio FA; Maleddu R; Costa G; Rocca R; Maccioni E; Catalano R; Romeo I; Eleftheriou P; Karia DC; Tsirides P; Godvani N; Pandya H; Corona A; Alcaro S; Artese A; Geronikaki A; Tramontano E
    Eur J Med Chem; 2019 Nov; 182():111617. PubMed ID: 31442684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
    Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of HQCAs with aryl or benzyl substituents on N-1 position as potential HIV-1 integrase inhibitors.
    He QQ; Zhang X; Wu HQ; Gu SX; Ma XD; Yang LM; Zheng YT; Chen FE
    Bioorg Med Chem; 2011 Sep; 19(18):5553-8. PubMed ID: 21862337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of novel bioisosteres of beta-diketo acid inhibitors of HIV-1 integrase.
    Sechi M; Sannia L; Carta F; Palomba M; Dallocchio R; Dessì A; Derudas M; Zawahir Z; Neamati N
    Antivir Chem Chemother; 2005; 16(1):41-61. PubMed ID: 15739621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
    Neamati N; Hong H; Mazumder A; Wang S; Sunder S; Nicklaus MC; Milne GW; Proksa B; Pommier Y
    J Med Chem; 1997 Mar; 40(6):942-51. PubMed ID: 9083483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.